St Vincent Frontier Cancer Center is a clinical research site located in Billings, Montana, United States 59102.
Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.
St Vincent Frontier Cancer Center has participated in 13 clinical trials with 6 currently active.
Therapeutic areas: Primary Immune Thrombocytopenia (ITP), Breast Cancer, Relapsed/Refractory Follicular Lymphoma.
Sponsors: Novartis Pharmaceuticals, BeiGene, Bristol-Myers Squibb.
Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
St Vincent Frontier Cancer Center has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
St Vincent Frontier Cancer Center has 13 clinical trials on record, with 6 currently active. Their work covers Primary Immune Thrombocytopenia (ITP), Breast Cancer, Relapsed/Refractory Follicular Lymphoma.
Yes — St Vincent Frontier Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.